Clinical Trials Browser

Terminated × Mastocytosis, Systemic × Myeloid × Clear all

NCT05609942 2025-04-10

AZURE

Phase 1 Terminated

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Mastocytosis, Systemic, Myelodysplastic-Myeloproliferative Diseases

NCT03214666 2022-11-10

GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies

Phase 1/2 Terminated

12 enrolled 20 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Mastocytosis, Systemic

NCT02415608 2018-09-20

Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis

Phase 2 Terminated

4 enrolled 14 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Mast-Cell, Mastocytosis, Systemic

NCT00918931 2011-11-04

Obatoclax for Systemic Mastocytosis

Phase 2 Terminated

3 enrolled 2 charts

MyeloidOther hematologic neoplasm

Leukemia, Mastocytosis, Systemic